United Medix Labs, Helsinki, Finland
United Medix Laboratories is a clinical central laboratory and analyses approx. 4 million tests annually within all branches of clinical laboratory analyses. Within the field of therapeutic drug monitoring the main aim is to provide drug level and anti-drug antibody analyses to help clinicians in personalizing use of biologicals.
The main diseases monitored:
- Crohn’s disease
- Ulcerative colitis
- Rheumatoid arthritis
- Psoriatic arthritis
- Measures infliximab, adalimumab, golimumab, etanercept, certolizumab pegol, vedolizumab, ustekinumab, and tocilizumab with ELISA.
- Measures ADA against infliximab, adalimumab, golimumab, etanercept, certolizumab pegol, vedolizumab, ustekinumab, and tocilizumab with radioimmunoassay (RIA) and Mass Spectrometry
Website link: https://www.yml.fi/en (Finnish and English)